Skip to main content
Erschienen in: International Urology and Nephrology 2/2013

01.04.2013 | Urology-Original Paper

Grading complications after transurethral resection of prostate using modified Clavien classification system and predicting complications using the Charlson comorbidity index

verfasst von: Swarnendu Mandal, Satya N. Sankhwar, Rohit Kathpalia, Manish Kumar Singh, Manoj Kumar, Apul Goel, Vishwajeet Singh, Rahul Janak Sinha, Bhupender Pal Singh, Divakar Dalela

Erschienen in: International Urology and Nephrology | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To retrospectively report and grade the peri-operative complications of transurethral resection of the prostate (TURP) using the modified Clavien classification system (MCCS) and validate whether Charlson comorbidity index (CCI) predicts the complications after TURP.

Materials and methods

Between September 2006 and 2012, data of 722 patients who underwent TURP were analyzed after excluding patients with incomplete data (n = 40). Data recorded included the age, prostate volume, operative time, mean prostatic tissue removed and duration of hospitalization while complications were recorded using the MCCS. Preexisting comorbidities were evaluated using the CCI, and patients were classified into 3 CCI score categories (0, 1, ≥2).

Results

Two hundred and forty-four complications were seen in 145 (20 %) patients. CCI score was “0” for 480 patients (66.5 %), “1” for 184 patients (25.5 %) and “≥2” for 58 patients (8 %). Significant difference was observed between patient groups with CCI score 0, 1 and ≥2 for mean age, prostatic weight, operative time, weight of prostatic chips and duration of hospitalization. Similarly, a significant difference in occurrence of various MCCS grades of complication among patients groups with different CCI score was observed.

Conclusion

Grades I, II and III complications constituted the main bulk (90 %) while grade IV were less common (<8 %) and grade V was rare (1 %) after TURP. Men with higher CCI score had a significantly higher rate of morbidity than those with a lower score. The present study is the first to validate that CCI can predict complications of TURP recorded according to the MCCS.
Literatur
1.
Zurück zum Zitat Reich O, Gratzke C, Bachmann A et al (2008) Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol 180:246–249PubMedCrossRef Reich O, Gratzke C, Bachmann A et al (2008) Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol 180:246–249PubMedCrossRef
2.
Zurück zum Zitat Lukacs B, Loeffler J, Bruyère F et al (2012) Photoselective vaporization of the prostate with Greenlight 120-W laser compared with monopolar transurethral resection of the prostate: a multicenter randomized controlled trial. Eur Urol 61(6):1165–1173PubMedCrossRef Lukacs B, Loeffler J, Bruyère F et al (2012) Photoselective vaporization of the prostate with Greenlight 120-W laser compared with monopolar transurethral resection of the prostate: a multicenter randomized controlled trial. Eur Urol 61(6):1165–1173PubMedCrossRef
3.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of a 6,336 patients and results of a survey. Ann Surg 240:205–213PubMedCrossRef Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of a 6,336 patients and results of a survey. Ann Surg 240:205–213PubMedCrossRef
4.
Zurück zum Zitat Rabbani F, Yunis HL, Pinochet R (2010) Comprehensive standardized report of complications of retropubic and laparoscopic radical prostatectomy. Eur Urol 57:371–386PubMedCrossRef Rabbani F, Yunis HL, Pinochet R (2010) Comprehensive standardized report of complications of retropubic and laparoscopic radical prostatectomy. Eur Urol 57:371–386PubMedCrossRef
5.
Zurück zum Zitat Ramasamy R, Afaneh C, Katz M et al (2011) Comparison of complications of laparoscopic versus laparo-endoscopic single site donor nephrectomy using the modified Clavien grading system. J Urol 186:1386–1390PubMedCrossRef Ramasamy R, Afaneh C, Katz M et al (2011) Comparison of complications of laparoscopic versus laparo-endoscopic single site donor nephrectomy using the modified Clavien grading system. J Urol 186:1386–1390PubMedCrossRef
6.
Zurück zum Zitat Szydełko T, Kasprzak J, Apoznan′ski W et al (2011) Clavien classification of complications after 150 laparoscopic pyeloplasties. Urology 77:1359–1364PubMedCrossRef Szydełko T, Kasprzak J, Apoznan′ski W et al (2011) Clavien classification of complications after 150 laparoscopic pyeloplasties. Urology 77:1359–1364PubMedCrossRef
7.
Zurück zum Zitat Ramasamy R, Afaneh C, Katz M et al (2011) Comparison of complications of laparoscopic versus laparoendoscopic single site donor nephrectomy using the modified Clavien grading system. J Urol 186(4):1386–1390PubMedCrossRef Ramasamy R, Afaneh C, Katz M et al (2011) Comparison of complications of laparoscopic versus laparoendoscopic single site donor nephrectomy using the modified Clavien grading system. J Urol 186(4):1386–1390PubMedCrossRef
8.
Zurück zum Zitat Mamoulakis C, Efthimiou I, Kazoulis S et al (2011) The modified Clavien classification system: a standardized platform for reporting complications in transurethral resection of the prostate. World J Urol 29:205–210PubMedCrossRef Mamoulakis C, Efthimiou I, Kazoulis S et al (2011) The modified Clavien classification system: a standardized platform for reporting complications in transurethral resection of the prostate. World J Urol 29:205–210PubMedCrossRef
9.
Zurück zum Zitat Mandal S, Goel A, Kathpalia R et al (2012) Prospective evaluation of complications using the modified Clavien grading system and success rates of percutaneous nephrolithotomy using guy’s stone score: a single center experience. Indian J Urol 28(4):392–398PubMedCrossRef Mandal S, Goel A, Kathpalia R et al (2012) Prospective evaluation of complications using the modified Clavien grading system and success rates of percutaneous nephrolithotomy using guy’s stone score: a single center experience. Indian J Urol 28(4):392–398PubMedCrossRef
10.
Zurück zum Zitat Mandal S, Goel A, Singh MK et al (2012) Clavien classification of semirigid ureteroscopy complications. A prospective study. Urology 80(5):995–1001PubMedCrossRef Mandal S, Goel A, Singh MK et al (2012) Clavien classification of semirigid ureteroscopy complications. A prospective study. Urology 80(5):995–1001PubMedCrossRef
11.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMedCrossRef Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMedCrossRef
12.
Zurück zum Zitat Guzzo TJ, Dluzniewski P, Orosco R et al (2010) Prediction of mortality after radical prostatectomy by Charlson comorbidity index. Urology 76:553–557PubMedCrossRef Guzzo TJ, Dluzniewski P, Orosco R et al (2010) Prediction of mortality after radical prostatectomy by Charlson comorbidity index. Urology 76:553–557PubMedCrossRef
13.
Zurück zum Zitat O’Connor KM, Davis N, Lennon GM et al (2009) Can we avoid surgery in elderly patients with renal masses by using the Charlson comorbidity index? BJU Int 103:1492–1495PubMedCrossRef O’Connor KM, Davis N, Lennon GM et al (2009) Can we avoid surgery in elderly patients with renal masses by using the Charlson comorbidity index? BJU Int 103:1492–1495PubMedCrossRef
14.
Zurück zum Zitat Unsal A, Resorlu B, Atmaca AF, AkifDiri A, Goktug HNG, Can CE et al (2012) Prediction of morbidity and mortality after percutaneous nephrolithotomy by using the Charlson comorbidity index. Urology 79(1):55–60PubMedCrossRef Unsal A, Resorlu B, Atmaca AF, AkifDiri A, Goktug HNG, Can CE et al (2012) Prediction of morbidity and mortality after percutaneous nephrolithotomy by using the Charlson comorbidity index. Urology 79(1):55–60PubMedCrossRef
15.
Zurück zum Zitat Resorlu B, Diri A, Atmaca AF et al (2012) Can we avoid percutaneous nephrolithotomy in high-risk elderly patients using the Charlson comorbidity index? Urology 79(5):1042–1047PubMedCrossRef Resorlu B, Diri A, Atmaca AF et al (2012) Can we avoid percutaneous nephrolithotomy in high-risk elderly patients using the Charlson comorbidity index? Urology 79(5):1042–1047PubMedCrossRef
16.
Zurück zum Zitat Rassweiler J, Teber D, Kuntz R et al (2006) Complications of transurethral resection of the prostate (TURP)—incidence, management, and prevention. Eur Urol 50:969–979PubMedCrossRef Rassweiler J, Teber D, Kuntz R et al (2006) Complications of transurethral resection of the prostate (TURP)—incidence, management, and prevention. Eur Urol 50:969–979PubMedCrossRef
17.
Zurück zum Zitat Furuya S, Furuya R, Ogura H et al (2006) A study of 4,031 patients of transurethral resection of the prostate performed by one surgeon: learning curve, surgical results and postoperative complications. Hinyokika Kiyo 52(8):609–614PubMed Furuya S, Furuya R, Ogura H et al (2006) A study of 4,031 patients of transurethral resection of the prostate performed by one surgeon: learning curve, surgical results and postoperative complications. Hinyokika Kiyo 52(8):609–614PubMed
18.
Zurück zum Zitat Xiong W, Sun M, Ran Q et al. (2012) Learning curve for bipolar Transurethral enucleation and resection of the prostate in saline for symptomatic benign prostatic hyperplasia: experience in the first 100 consecutive patients. Urol Int. [Epub ahead of print] Xiong W, Sun M, Ran Q et al. (2012) Learning curve for bipolar Transurethral enucleation and resection of the prostate in saline for symptomatic benign prostatic hyperplasia: experience in the first 100 consecutive patients. Urol Int. [Epub ahead of print]
19.
Zurück zum Zitat Fitzpatrick JM (2007) Minimally invasive and endoscopic management of benign prostatic hyperplasia. In: Kavoussi LR, Partin AW, Novick AC (eds) Campbell-walsh urology, 9th edn. Saunders, Philadelphia, p 2832 Fitzpatrick JM (2007) Minimally invasive and endoscopic management of benign prostatic hyperplasia. In: Kavoussi LR, Partin AW, Novick AC (eds) Campbell-walsh urology, 9th edn. Saunders, Philadelphia, p 2832
20.
Zurück zum Zitat Hong JY, Yang SC, Ahn S et al (2011) Preoperative comorbidities and relationship of comorbidities with postoperative complications in patients undergoing transurethral prostate resection. J Urol 185:1378–1384 Hong JY, Yang SC, Ahn S et al (2011) Preoperative comorbidities and relationship of comorbidities with postoperative complications in patients undergoing transurethral prostate resection. J Urol 185:1378–1384
21.
Zurück zum Zitat Djavan B, Madersbacher S, Klingler C et al (1997) Urodynamic assessment of patients with acute urinary retention: is treatment failure after prostectomy predictable? J Urol 158:1829–1833PubMedCrossRef Djavan B, Madersbacher S, Klingler C et al (1997) Urodynamic assessment of patients with acute urinary retention: is treatment failure after prostectomy predictable? J Urol 158:1829–1833PubMedCrossRef
22.
Zurück zum Zitat Kuntz RM, Ahyai S, Lehrich K et al (2004) Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospective trial in 200 patients. J Urol 172:1012–1016PubMedCrossRef Kuntz RM, Ahyai S, Lehrich K et al (2004) Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospective trial in 200 patients. J Urol 172:1012–1016PubMedCrossRef
23.
Zurück zum Zitat Colau A, Lucet JC, Rufat P et al (2001) Incidence and risk factors of bacturia after transurethral resection of the prostate. Eur Urol 39(3):272–276PubMedCrossRef Colau A, Lucet JC, Rufat P et al (2001) Incidence and risk factors of bacturia after transurethral resection of the prostate. Eur Urol 39(3):272–276PubMedCrossRef
24.
Zurück zum Zitat Holtgrewe HL, Valk WL (1962) Factors influencing the mortality and morbidity of transurethral prostatectomy: a study of 2,015 cases. J Urol 87:450–459PubMed Holtgrewe HL, Valk WL (1962) Factors influencing the mortality and morbidity of transurethral prostatectomy: a study of 2,015 cases. J Urol 87:450–459PubMed
25.
Zurück zum Zitat Madersbacher S, Lackner J, Brössner C et al (2005) Prostate study group of the austrian society of urology. Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nation-wide, long-term analysis of 23,123 cases. Eur Urol 47:499–504PubMedCrossRef Madersbacher S, Lackner J, Brössner C et al (2005) Prostate study group of the austrian society of urology. Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nation-wide, long-term analysis of 23,123 cases. Eur Urol 47:499–504PubMedCrossRef
26.
Zurück zum Zitat Madersbacher S, Marberger M (1999) Is transurethral resection of the prostate still justified? BJU Int 83:227–237PubMedCrossRef Madersbacher S, Marberger M (1999) Is transurethral resection of the prostate still justified? BJU Int 83:227–237PubMedCrossRef
27.
Zurück zum Zitat Morgan M, Smith NS, Thomas K et al (2009) Is Clavien the new standard for reporting urological complications? BJU Int 104:434–436PubMedCrossRef Morgan M, Smith NS, Thomas K et al (2009) Is Clavien the new standard for reporting urological complications? BJU Int 104:434–436PubMedCrossRef
28.
Zurück zum Zitat Graefen M (2010) The modified Clavien system: a plea for a standardized reporting system for surgical complications. Eur Urol 57:387–389PubMedCrossRef Graefen M (2010) The modified Clavien system: a plea for a standardized reporting system for surgical complications. Eur Urol 57:387–389PubMedCrossRef
Metadaten
Titel
Grading complications after transurethral resection of prostate using modified Clavien classification system and predicting complications using the Charlson comorbidity index
verfasst von
Swarnendu Mandal
Satya N. Sankhwar
Rohit Kathpalia
Manish Kumar Singh
Manoj Kumar
Apul Goel
Vishwajeet Singh
Rahul Janak Sinha
Bhupender Pal Singh
Divakar Dalela
Publikationsdatum
01.04.2013
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 2/2013
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-013-0399-x

Weitere Artikel der Ausgabe 2/2013

International Urology and Nephrology 2/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.